AstraZeneca shares fall as China probe intensifies

Ian Johnston and Eleanor Olcott and Wang Xueqiao
5 min read

In This Article:

AstraZeneca shares fell 8.4 per cent on Tuesday as a corruption purge involving its China chief risked spiralling wider, clouding the

Upgrade to read this Financial Times article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.

Recommended Stories